LO BIOSCIENCES, INC.

Medtech · Private

P1 device for at-home plasma separation using magnetic bead-based blood cell capture

Grants
$1.6M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · RFA-PA-21-259- Highly sensitive point-of-care LAMP assay for diagnosis of HCV infection enabled by PBMC-enriched plasma$259,002
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · A novel remote blood separation device for at-home plasma collection for HIV-1 testing$994,658
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Home-based plasma self-collection device for remote diagnosis and monitoring of AD-associated biomarkers$305,621
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1957ENDOMIMETICS LLC——
1958SPINEX, INC.——
1959ALLAY THERAPEUTICS INC——
1960LO BIOSCIENCES, INC.——
1961ESCHARA MEDICAL, LLC——
1962TRANZ BIOSCIENCES, LLC——
1963GAiTE LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Magnetic Capture Deviceapplication
  • Magnetic Capture Deviceapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.